[Low molecular weight dextrans (Rheomacrodex) in the therapy of inner ear hearing loss].
The treatment of the defective hearing of the inner ear with infusions shows surprisingly good success both with the sudden and gradual loss of hearing. The combination of low molecular Dextrans with Vincamin has produced the best results. Neither failure nor noxiousness of this therapy of the sudden loss of hearing could be observed.
D001301:Audiometry, Pure-Tone; D003051:Cochlea / Q000098:blood supply*; D003911:Dextrans / Q000627:therapeutic use*; D006319:Hearing Loss, Sensorineural / Q000628:therapy*; D003639:Hearing Loss, Sudden / Q000628:therapy; D006801:Humans; D007262:Infusions, Intravenous; D007511:Ischemia / Q000628:therapy*; D008970:Molecular Weight; D012212:Rheology; D014749:Vincamine / Q000627:therapeutic use
D003911:Dextrans; D014749:Vincamine
Niedermolekulare Dextrane (Rheomacrodex) in der Therapie der Innenohrschwerhörigkeit.